Meanwhile, CRLF2 rearrangements are a significant genetic alteration in ALL, particularly within the Ph-like B-ALL subtype, a high-risk subgroup of B-ALL that may benefit from TKIs, where they occur in approximately 50% of cases [94,140]. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.